EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horejsi, R.
Right arrow Articles by Tafeit, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horejsi, R.
Right arrow Articles by Tafeit, E.
Experimental Biology and Medicine 227:794-798 (2002)
© 2002 Society for Experimental Biology and Medicine


ORIGINAL ARTICLE

Differences of Subcutaneous Adipose Tissue Topography Between Type-2 Diabetic Men and Healthy Controls

Renate Horejsi*, Reinhard Möller*, Thomas R. Pieber{dagger}, Sandra Wallner{dagger}, Karl Sudi{ddagger}, Gilbert Reibnegger* and Erwin Tafeit1,*

* Institute for Medical Chemistry and Pregl Laboratory, Karl-Franzens-University of Graz, A-8010 Graz, Austria; and
{dagger} Department of Internal Medicine and
{ddagger} Institute for Sport Sciences, Karl-Franzens-University of Graz, A-8010 Graz, Austria


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Men with noninsulin-dependent diabetes mellitus (type 2 DM) provide a different subcutaneous body fat distribution and a concentration of fatness on the upper trunk compared with healthy subjects. However, subcutaneous fat distribution is always measured in an inaccurate and/or very simplified way (e.g., by caliper), and to date, there exists no study reporting on the exact and complete subcutaneous adipose tissue distribution of type 2 DM men. A new optical device, the LIPOMETER, enables the nonivasive, quick, and safe determination of the thickness of subcutaneous adipose tissue layers at any given site of the human body. The specification of 15 evenly distributed body sites allows the precise measurement of subcutaneous body fat distribution, so-called subcutaneous adipose tissue topography (SAT-Top). SAT-Tops of 21 men with clinically proven type 2 DM (mean age of 57.5 ± 6.7 years) and 111 healthy controls of similar age (mean age 59.0 ± 5.4 years) were measured. In this paper, we describe the precise SAT-Top differences of these two groups and we present the multidimensional SAT-Top information condensed in a two-dimensional factor value plot. In type 2 DM men, especially in the upper trunk, SAT-Top is significantly increased (up to +50.7% at the neck) compared with their healthy controls. One hundred eleven of the 132 individuals (84.1%) are correctly classified (healthy or type 2 DM) by their subcutaneous fat pattern by stepwise discriminant analysis.

Key Words: fat distribution • body composition • LIPOMETER • subcutaneous fat • metabolic disorders


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Obesity is a well-known risk factor for noninsulin-dependent diabetes mellitus (type 2 DM) in men. Some studies report on a relationship between type 2 DM and an excess of visceral adipose tissue (1, 2), whereas others also found correlations between body fat distribution and the disease (3, 2, 4), especially, a concentration of fatness on the upper part of the body (5, 6). Visceral adipose tissue can be assessed more or less accurate (e.g., by computed tomography [CT] of fat areas or simply by waist circumference), whereas subcutaneous fat distribution is always measured in an inaccurate (caliper) and/or very simplified way (CT cuts at two or three levels). Until today, there has been no study reporting on the complete subcutaneous adipose tissue (SAT) distribution of type 2 DM men.

The new optical device, LIPOMETER (EU patent number 0516251), enables a noninvasive, quick, precise, and safe determination of the thickness of SAT layers at any given site of the human body. The technical characteristics of the measurement system and a first validation of the results using CT as reference method have already been published (79). Fifteen well-defined body sites were specified (10), providing a SAT topography (SAT-Top) of the human body. SAT-Top includes the complete subcutaneous fat distribution information of a subject, which is like an individual ``fingerprint.''

Previously, we could show the enormous SAT-Top differences between women with type 2 DM and healthy controls (1114), suggesting the LIPOMETER technique as a possible type 2 DM predictor. In the present paper, we want to present the exact and complete subcutaneous fat distribution of type 2 DM men, and the SAT-Top differences between type 2 DM men and healthy controls.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Diabetic Subjects.
A group of 21 men with clinically overt type 2 DM was recruited at the university hospital of Graz to provide their SAT-Top values. Their descriptive statistics are presented in Table IGo.


View this table:
[in this window]
[in a new window]
 
Table I. Descriptive Statistics (mean value ± SD [min - max]) of SAT-Top’s of 21 Type 2 DM Men and 111 Healthy Controls of the Same Age Group
 
Healthy Subjects.
As a part of a ``health and fitness check,'' SAT-Top was measured in 111 ``healthy'' men for comparison with type 2 DM men. Fasting glucose levels below 110 mg/dl were defined as nontype 2 DM. Only men who were not suffering from a chronic disease were selected for the ``healthy'' group. Their personal characteristics are also presented in Table IGo.

Measurement of SAT-Top.
The new optical device, LIPOMETER, consists of light-emitting diodes as light sources and a photodetector. The light-emitting diodes illuminate the selected SAT layer, forming geometrically varying light patterns in succession. The photodiode detects the corresponding light intensities backscattered, which are amplified, digitized, and calculated into absolute values of SAT thickness (in millimeters). For validation of the LIPOMETER, CT was applied as reference method (7, 8). Notably, the LIPOMETER renders the absolute thickness of a SAT monolayer, which, for example, cannot be compared with the results of the well-known caliper, providing the thickness of a compressed skinfold including a double layer of skin.

To determine SAT-Top of an individual, the LIPOMETER is applied to measure the thickness (in millimters) of 15 specified SAT layers, which were previously depicted and described (10, 14). Measurements were performed on the right body side while subjects were standing. The body sites are evenly distributed over the whole body and are top-down sorted from neck to calf. The measurement results can be summarized as SAT-Top, describing precisely the subcutaneous fat distribution pattern of a subject (10).

Statistics.
Statistical calculations were performed using SPSS for Windows (SPSS, Inc., Chicago, IL). The hypothesis of variables being normally distributed was tested by KOLMOGOROV-SMIRNOV test. Differences in the distributions of variables between healthy and type 2 DM men were tested by the Student’s t test for independent samples (for normally distributed variables) and the Mann-Whitney U test (if variables were not normally distributed).

The 15 SAT-Top body sites, which are spread over the whole body, describe a detailed subcutaneous fat topography of a subject. Some of these sites are situated on the same body region (e.g., on the legs: sites 11–15) Consequently, they provide a similar fat development. To investigate the concluded SAT-Top information of complete body regions (e.g. upper trunk, arms, etc.), additional variables were calculated by summarizing the corresponding body sites:


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The distributions of the 15 SAT layer thicknesses of healthy and type 2 DM men were tested by KOLMOGOROV-SMIRNOV test. The test provides no significant deviation from being normally distributed (P > 0.05) for most SAT-Top variables (only the body sites 12, 13, and 15 showed a P < 0.05 in healthy men), all summarized variables of the four body regions, and total SAT thickness. According to these results, the Student’s t test for independent samples (in case of normally distributed variables) or the Mann-Whitney U test (otherwise) are applied to investigate the SAT layer differences between healthy and type 2 DM men.

Significant SAT-Top differences between the two groups are observed in all layers of the upper trunk (sites 1, and 4–6), the arms (sites 2 and 3), and the legs (sites 11–15), whereas most of the thicknesses of the middle part of the body, the abdominal region (sites 7, 8, and 10), are not significantly different (Table IGo). Generally, in case of statistical significance, type 2 DM men had thicker SAT layers (+0.6 to +5.0 mm) compared with their healthy controls (Fig. 1Go), whereby the greatest absolute difference (+5 mm) appears at the highest situated measurement point of the body, the neck. Figure 2Go shows the distributions of this body site for both groups of men as box plots, whereby the measurement results of the type 2 DM men overlap less than 50% of the healthy cases. Slight absolute differences are observed on the legs.



View larger version (38K):
[in this window]
[in a new window]
 
Figure 1. A SAT-Top plot for healthy and type 2 DM men. The body sites are sorted top-down: 1 through 6 are related to the upper trunk and arms, 7 through 10 are related to the lower trunk region, and 11 through 15 are related to the legs. Therefore, the SAT pattern of the different groups can be recognized easily. The highest deviation between healthy and type 2 DM men occurs at the body site 1-neck.

 


View larger version (23K):
[in this window]
[in a new window]
 
Figure 2. Boxplots to show the SAT thickness distribution of the body site 1-neck, which provides the greatest absolute difference between type 2 DM men (type 2 DM = 1) and healthy controls (type 2 DM = 0).

 
Relative differences are presented in Figure 3Go, showing high percent values at the upper trunk (+22.7 to +50.7%) and the arms (+22.8 to +50.6%), and lower values at the legs (+21.6 to +28.3%). These results are confirmed more clearly by the summarized variables, providing great relative differences for upper trunk (+36.8%) and arms (+35.1%), small differences for lower trunk (+13.4%), and medium differences for legs (+24.9%), between the two groups of men (Table IGo). All summarized variables are normally distributed and show significant differences (Table IGo).



View larger version (36K):
[in this window]
[in a new window]
 
Figure 3. Relative SAT-Top plot. The means of healthy men are set to 100%. The deviation for the means of type 2 DM men body sites is especially high for the body sites 1-neck (+50.7%) and 3-biceps (+50.6%).

 
Furthermore, type 2 DM men have significantly more total subcutaneous fat thickness (+25%) compared with their healthy controls (Table IGo).

The results of factor analysis are presented in Figure 4Go, and the means of the two factors are shown in Table IGo. Factor 1 corresponds to subcutaneous trunk body fat development, whereas factor 2 is related to extremities SAT-Top. Only factor 1 is significantly different in the two groups (Table IGo). Type 2 DM men provide higher trunk SAT-Top and slightly higher (but not significant, P = 0.076) extremity SAT-Top than their healthy controls. These results are also depicted in Figure 4Go, where type 2 DM men (md) are compared with their healthy control group (mh), with type 2 DM women (wd), and with the different age groups of healthy men (m1, . . . , m5) and healthy women (w1, . . . , w5). In healthy men, trunk SAT-Top (factor 1) increases continuously through the first three age stages; afterward, it decreases slightly, and it develops even beyond the highest healthy age group (m3: 40–50 years) in type 2 DM men. On the contrary, extremity SAT-Top of type 2 DM men is slightly higher compared with their healthy controls. Therefore, type 2 DM men are situated between the group of all healthy men and type 2 DM women.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 4. A factor value plot showing different age groups of healthy men (m1: 20–30 years, . . . , m5: 60–70 years) healthy women (w1: 20–30 years, . . . , w5: 60–70 years) (10), type 2 DM women (wd), age-matched healthy women (wh) for comparison with wd in relation to the two factors (14), type 2 DM men (md), and healthy men (mh) for comparison with md. A 95% confidence ellipse is presented for the means of wd, wh, md, and mh. Factor 1 (x-coordinate) describes the subcutaneous trunk fat development of the different groups. Factor 1 values >0 correspond to a trunk fat development above average (e.g., diabetic subjects wd and md), factor 1 values <0 show a trunk SAT development below average (e.g., healthy women [w1] and men [m1] of the age group 1: 20–30 years. Factor 2 values (y-coordinate) correspond to the extremities SAT development, e.g., healthy women (w1, . . . , w5, and wh) provide thicker SAT values at the extremities, while healthy men (m1, . . . . . , m5. and mh), diabetic women (wd) and diabetic men (md) have an extremity SAT development below average.

 
Finally, all 15 SAT-Top values, age, height, weight, factor 1, and factor 2, are used as input for discriminant analysis. For 21 type 2 DM men and 111 healthy controls, the following classification results are provided: 84.1% of the 132 individuals are correctly classified by stepwise discriminant analysis (sensitivity = 81%; specificity = 84.7%), selecting the three body sites 1-neck, 4-upper back, and 8-lower abdomen for the discriminant function. The result is improved to 84.8% by the method of including all independent variables. Notably, out of all values presented to the discriminant analysis, only SAT-Top values were selected for the discriminant functions.


    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Though obesity is a well-known risk factor for type 2 DM, to date, there exists only accurate studies concerning the visceral body fat, whereas papers investigating the role of body fat distribution have always had to fight the problem of inaccurate and/or very simplified measurement methods. The LIPOMETER technique enables quick, safe, and precise determination of the subcutaneous fat distribution of the human body, which allows for the presention of an exact SAT-Top description of men suffering from type 2 DM in this paper.

The group of men suffering from type 2 DM provided significantly more subcutaneous fat (+25%) than their healthy controls, though height, weight, and BMI were not significantly different. Previous papers presented healthy and type 2 DM subjects with comparable height, weight, and/or BMI showing a slightly but not significantly higher amount of subcutaneous fat in diabetics (24). These papers report on differences in the SAT distribution between healthy and type 2 DM men, which confirm our results.

Hyperandroid and android subjects were assigned a higher risk for type 2 DM by Vague (5), who presented pictures of extreme android and gynoid obese men and women, showing the stronger pronounced upper body obesity of the android fat pattern. Shuman et al. (2) found greater, but not significantly different thorax fat areas (by CT) in type 2 DM men compared with healthy controls, Mueller et al. (4) reported on significantly thicker subscapular skinfolds (by Lange caliper) in male diabetics, and Abate et al. (3) presented significantly higher midaxillary and subscapular skinfolds (by Lange caliper) for type 2 DM men, confirming our results of significantly higher SAT values at the body sites 4-upper back and 6-lateral chest. Notably, all of these results are measures for the android fat pattern. The advantage of our study seems to be the presentation of the complete SAT-Top for healthy and type 2 DM men, showing many of measurement points for each body region, which enables the recognition of the whole subcutaneous fat pattern and the finding of the most important body sites. Though all body sites of the upper trunk are significantly increased in type 2 DM men, the body site 1-neck (which is the highest situated body site) is the most important among them (Fig. 2Go; see also Figures 3Go–6 in Ref. 5), whereas 6-lateral chest seems to be situated a little bit too low on the body to be a good measure for the android fat pattern.

As we could previously show in type 2 DM women (14), SAT-Top results of the abdominal region are not of great importance. Furthermore, leg SAT-Top provides not much information in male diabetics, whereas in women, who normally have much more SAT on the legs than men, the reduction of leg fat in case of type 2 DM is of great importance.

Due to the more pronounced (upper) trunk obesity, the group of male type 2 DM patients is situated on the right side of healthy men and much closer to the group of type 2 DM women than their healthy controls (Fig. 4Go).

Mueller et al. (4), who measured five skinfold thicknesses (triceps, subscapular, waist, medial, and lateral calf), reported on a low discriminating power of the calculated skinfold discriminant function. Our stepwise discriminant analysis provided good results (84.1% correct classification), which even surpassed our findings for healthy and type 2 DM women (81% correct classification) (14).

We hope that these results obtained by the SAT-Top approach will contribute to the still ongoing search for type 2 DM predictors. It is worth emphasizing that the LIPOMETER measures only subcutaneous fat, providing good classification results even without the consideration of visceral fat. The additional use of common methods like WHR, BMI, and/or waist circumference, which provide information about the visceral fat, might even improve the classification results.


    Acknowledgments
 
The LIPOMETER was developed as a research tool for clinical and preclinical studies. All authors are employed at the University and have no commercial interests concerning this device.


    Footnotes
 
1 To whom requests for reprints should be addressed at Prof. Dr. Erwin Tafeit, Medizinisch-Chemisches Institut und Pregl-Labor, Harrachgasse 21/II, A-8010 Graz, Austria. E-mail: erwin.tafeit{at}kfunigraz.ac.at Back


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Bjorntorp P. The origins and consequences of obesity. Diabetes Ciba Found Symp 201:68–80, discussion 80–89, –193, 1996.
  2. Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, Fujimoto WY. Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 21:483–487, 1986.[Medline]
  3. Abate N, Garg A, Peshock RM, Stray Gundersen J, Adams Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes45(12):1684–1693, 1996.[Abstract]
  4. Mueller WH, Joos SK, Hanis CL, Zavaleta AN, Eichner J, Schull WJ. The Diabetes Alert study: growth, fatness, and fat patterning, adolescence through adulthood in Mexican Americans. Am J Phys Anthropol 64:389–399, 1984.[Medline]
  5. Vague J. The degree of masculine differentiation of obesity: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 4:20–34, 1956.[Abstract]
  6. Szathmary EJE, Holt N. Hyperglycemia in Dogrib Indians of the Northwest Territories, Canada: association with age and a centripetal distribution of body fat. Hum Biol 55:493–515, 1983.[Medline]
  7. Möller R, Tafeit E, Smolle KH, Kullnig P. Lipometer: determining the thickness of a subcutaneous fatty layer. Biosens Bioelectron 9(6):xiii–xvi, 1994.[Medline]
  8. Möller R, Tafeit E, Smolle KH, Pieber TR, Ipsiroglu O, Duesse M, Huemer C, Sudi K, Reibnegger G. Estimating percentage total body fat and determining subcutaneous adipose tissue distribution with a new non-invasive optical device LIPOMETER. Am J Hum Biol 12:221–230, 2000.
  9. Tafeit E, Möller R, Sudi K, Reibnegger G. Artificial neural networks as a method to improve the precision of subcutaneous adipose tissue thickness measurements by means of the optical device LIPOMETER. Comput Biol Med 30:355–365, 2000.[Medline]
  10. Möller R, Tafeit E, Pieber TR, Sudi K, Reibnegger G. Measurement of subcutaneous adipose tissue topography (SAT-Top) by means of a new optical device, LIPOMETER, and the evaluation of standard factor coefficients in healthy subjects. Am J Hum Biol 12:231–239, 2000.
  11. Tafeit E, Möller R, Sudi K, Reibnegger G. The determination of three subcutaneous adipose tissue compartments in non-insulin-dependent diabetes mellitus women with artificial neural networks and factor analysis. Artif Intell Med 17:181–193, 1999.[Medline]
  12. Möller R, Tafeit E, Sudi K, Reibnegger G. Quantifying the ``appleness'' or ``pearness'' of the human body by subcutaneous adipose tissue distribution. Ann Hum Biol 27:47–55, 2000.[Medline]
  13. Tafeit E, Möller R, Sudi K, Reibnegger G. ROC and CART analysis of subcutaneous adipose tissue topography (SAT-Top) in type-2 diabetic women and healthy females. Am J Hum Biol 12:388–394, 2000.
  14. Tafeit E, Möller R, Pieber TR, Sudi K, Reibnegger G. Differences of subcutaneous adipose tissue topography in type-2 diabetic (NIDDM) women and healthy controls. Am J Phys Anthropol 113:381–388, 2000.[Medline]
  15. Mueller WH, Reid RM. A multivariate analysis of fatness and relative fat patterning. Am J Phys Anthropol 50:199–208, 1979.[Medline]
Received for publication February 25, 2002. Accepted for publication May 21, 2002.




This article has been cited by other articles:


Home page
Diabetes CareHome page
R. L. Weinstein, S. L. Schwartz, R. L. Brazg, J. R. Bugler, T. A. Peyser, and G. V. McGarraugh
Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System: Comparison with frequent laboratory reference measurements
Diabetes Care, May 1, 2007; 30(5): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. Tafeit, R. Moller, S. Rackl, A. Giuliani, W. Urdl, U. Freytag, K. Crailsheim, K. Sudi, and R. Horejsi
Subcutaneous Adipose Tissue Pattern in Lean and Obese Women with Polycystic Ovary Syndrome
Experimental Biology and Medicine, June 1, 2003; 228(6): 710 - 716.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horejsi, R.
Right arrow Articles by Tafeit, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horejsi, R.
Right arrow Articles by Tafeit, E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS